Literature DB >> 20573636

Efficacy of catheter ablation and surgical CryoMaze procedure in patients with long-lasting persistent atrial fibrillation and rheumatic heart disease: a randomized trial.

Xu Liu1, Hong-Wei Tan, Xin-Hua Wang, Hai-Feng Shi, Ying-Ze Li, Feng Li, Li Zhou, Jia-Ning Gu.   

Abstract

AIMS: Catheter ablation and surgical Maze procedure are effective in treating atrial fibrillation (AF) patients. However, there is no study that compares the effect of circumferential pulmonary vein isolation (CPVI) combined with substrate ablation after valvular surgery and the concomitant Maze procedure for the treatment of AF in patients with rheumatic heart disease (RHD). The aim of this study was to compare the effectiveness of CPVI combined with substrate modification and surgical Maze procedure using Saline-Irrigated Cooled-tip Radiofrequency Ablation (SICTRA) system for the treatment of long-lasting persistent AF in patients with RHD. METHODS AND
RESULTS: Between January 2006 and June 2008, 99 patients with long-lasting persistent AF and RHD were randomly assigned to undergo valvular operation and CPVI combined with substrate modification 6 months after the surgery (Group A, 49 patients) or valvualr operation and concomitant Maze procedure (Group B, 50 patients). The mean follow-up periods were 15 ± 5 and 20 ± 8 months in Groups A and B, respectively. After one procedure, Group B had a significantly higher freedom from artial arrhythmias compared with Group A (82% in Group B vs. 55.2% in Group A, P < 0.001). Fifteen patients in Group A underwent a redo procedure. Six patients in Group B underwent catheter ablation and four were treated successfully. The cumulative rates of sinus rhythm were 71% in Group A and 88% in Group B (P < 0.001).
CONCLUSION: The concomitant Cox Maze procedure using SICTRA is more effective than subsequent CPVI combined with substrate modification in treating patients with long-lasting persistent AF and RHD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573636     DOI: 10.1093/eurheartj/ehq201

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease.

Authors:  Yu Sun; Zi-Yang Huang; Zhen-Hua Wang; Cui-Ping Li; Xian-Liang Meng; Yun-Jiao Zhang; Feng Su; Nan Ma
Journal:  Mol Cell Biochem       Date:  2015-05-14       Impact factor: 3.396

Review 2.  Concomitant atrial fibrillation surgery for people undergoing cardiac surgery.

Authors:  Mark D Huffman; Kunal N Karmali; Mark A Berendsen; Adin-Cristian Andrei; Jane Kruse; Patrick M McCarthy; S C Malaisrie
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

3.  Morphine but not fentanyl and methadone affects mitochondrial membrane potential by inducing nitric oxide release in glioma cells.

Authors:  D Mastronicola; E Arcuri; M Arese; A Bacchi; S Mercadante; P Cardelli; G Citro; P Sarti
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

4.  Renal function after repeat catheter ablation for long-standing persistent atrial fibrillation : Low CHA2DS2-VASc score and sinus rhythm predict improved renal function.

Authors:  Q Wang; X-D Zhang; X Liu; Y-Q Yang
Journal:  Herz       Date:  2016-01-25       Impact factor: 1.443

5.  Effect of pulmonary vein isolation on atrial fibrillation recurrence after ablation of paroxysmal supraventricular tachycardia in patients with high dispersion of atrial refractoriness.

Authors:  Zhen-xing Xu; Jing-quan Zhong; Bing Rong; Xin Yue; Zhao-tong Zheng; Qing Zhu; Shao-lei Yi; Jun-tao Wang; Man Li; Yun Zhang
Journal:  J Interv Card Electrophysiol       Date:  2014-09-17       Impact factor: 1.900

6.  Ablation of atrial tachycardia occurring after catheter ablation of atrial fibrillation in patients with corrected rheumatic valve disease.

Authors:  Xin-Hua Wang; Cong-Xin Huang; Xu Liu; Hai-Feng Shi; Hong-Wei Tan; Wei-Feng Jiang; Yuan-Long Wang
Journal:  J Interv Card Electrophysiol       Date:  2012-05-11       Impact factor: 1.900

7.  Very early recurrence predicts long-term outcome in patients after atrial fibrillation catheter ablation: a prospective study.

Authors:  Yangjing Xue; Xiaoning Wang; Saroj Thapa; Luping Wang; Jiaoni Wang; Zhiqiang Xu; Shaoze Wu; Luyuan Tao; Guoqiang Wang; Lu Qian; Lianming Liao; Baohua Liu; Kangting Ji
Journal:  BMC Cardiovasc Disord       Date:  2017-05-08       Impact factor: 2.298

8.  Comparison of the Efficacy and Safety Endpoints of Five Therapies for Atrial Fibrillation: A Network Meta-Analysis.

Authors:  Tongyu Wang; Tingting Fang; Zeyi Cheng
Journal:  Front Cardiovasc Med       Date:  2022-06-03

9.  Association of angiotensin-converting enzyme gene I/D and CYP11B2 gene -344T/C polymorphisms with lone atrial fibrillation and its recurrence after catheter ablation.

Authors:  Xian-Ling Zhang; Li-Qun Wu; Xu Liu; Yi-Qing Yang; Hong-Wei Tan; Xin-Hua Wang; Li Zhou; Wei-Feng Jiang; Zheng Li
Journal:  Exp Ther Med       Date:  2012-07-31       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.